2,772 followers
Fondaparinux administration and early disease-stage CRC were risk factors for postoperative bleeding in patients with pharmacological thromboprophylaxis undergoing surgical treatment for CRC. @OncoBioMed https://t.co/NRjNUC6khB https://t.co/xVGuC7SfLl